Cite

HARVARD Citation

    Himmler, S. et al. (2019). Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study. Expert review of pharmacoeconomics & outcomes research. pp. 223-230. [Online]. 
  
Back to record